Servaas A. Morre

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Effect of medical-grade honey (L-Mesitran) for cervical intraepithelial neoplasia II: protocol for a multicentre cohort pilot study (HONEY FOR CIN II study).

Effect of medical-grade honey (L-Mesitran) for cervical intraepithelial neoplasia II: protocol for a multicentre cohort pilot study (HONEY FOR CIN II study).

Journal: BMJ open
Published: July 24, 2025

ProVag: the effect of oral probiotics on the vaginal microbiota composition in women receiving medical assisted reproduction in a Dutch fertility clinic - protocol of a randomised, placebo-controlled, double-blind study.

ProVag: the effect of oral probiotics on the vaginal microbiota composition in women receiving medical assisted reproduction in a Dutch fertility clinic - protocol of a randomised, placebo-controlled, double-blind study.

Journal: BMJ open
Published: July 09, 2025

A review of zoonotic chlamydiae species in Africa: assessing their burden and potential impact through One Health perspective.

A review of zoonotic chlamydiae species in Africa: assessing their burden and potential impact through One Health perspective.

Journal: One health outlook
Published: May 20, 2025

Prevalence of genital and anorectal chlamydia trachomatis in Kenya by risk groups: a systematic review and meta-analysis.

Prevalence of genital and anorectal chlamydia trachomatis in Kenya by risk groups: a systematic review and meta-analysis.

Journal: BMC infectious diseases
Published: April 16, 2025

Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.

Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.

Journal: International journal of molecular sciences
Published: March 19, 2025

Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study.

Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study.

Journal: PloS one
Published: December 02, 2024

Editorial: Gut microbiota and immunity in health and disease: dysbiosis and eubiosis's effects on the human body.

Editorial: Gut microbiota and immunity in health and disease: dysbiosis and eubiosis's effects on the human body.

Journal: Frontiers in immunology
Published: November 28, 2024

The importance of understanding pelvic inflammatory disease as a polymicrobial infection - authors' reply.

The importance of understanding pelvic inflammatory disease as a polymicrobial infection - authors' reply.

Journal: The Lancet regional health. Europe
Published: October 17, 2024

Clinical Applicability of Microbiota Sampling in a Subfertile Population: Urine versus Vagina.

Clinical Applicability of Microbiota Sampling in a Subfertile Population: Urine versus Vagina.

Journal: Microorganisms
Published: July 19, 2024

Chlamydia trachomatis infections in Kenya - sexually transmitted and ocular infections: a scoping review.

Chlamydia trachomatis infections in Kenya - sexually transmitted and ocular infections: a scoping review.

Journal: Therapeutic advances in reproductive health
Published: April 30, 2024

Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs.

Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs.

Journal: Microorganisms
Published: April 25, 2024

Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022.

Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022.

Journal: The Lancet regional health. Europe
Published: February 22, 2024
Showing 1-12 of 127

Last Updated: 09/26/2026